If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

Ultimately, the right stocks for your portfolio will depend on numerous factors, including your risk tolerance level, ...

Get the Levels app & CGM sensors: <a href=" in mind that everyones body is different, but I wore a continuous glucose monitor ...

Discover how continuous glucose monitoring can revolutionize your health. Learn how to optimize your diet and exercise with ...